The Government has established criteria for selecting the only suppliers for public procurement of medicines
From January 1, 2024, a number of requirements will be presented to the only suppliers of medicines for medical use, which are determined by acts of the government or the president.
The future counterparty must:
be a legal entity and produce the drug at all stages on the territory of the member states of the Eurasian Economic Union;
it is not under the control of a foreign investor or a group of persons;
have over the past 3 years experience in the supply of medicines for medical use within the framework of state contracts or contracts under Federal Law No. 223;
have a patent for the active substance. The document must be valid for at least the period for which such a supplier was chosen.
They also listed the criteria for selecting medicines for such purchases.
Document: Resolution of the Government of the Russian Federation of 16.05.2023 N 753